Low DBP may not be an independent risk for cardiovascular death in revascularized coronary artery disease patients
暂无分享,去创建一个
Takeshi Kimura | T. Kita | T. Ueno | T. Imaizumi | Y. Furukawa | H. Kai | H. Adachi
[1] A. Koike,et al. Impact of reduced renal function on prognosis in Japanese patients with coronary artery disease: a prospective cohort of Shinken Database 2007 , 2009, Hypertension Research.
[2] F. Messerli,et al. Characteristics and Outcomes of Revascularized Patients With Hypertension: An International Verapamil SR-Trandolapril Substudy , 2009, Hypertension.
[3] Takeshi Kimura,et al. Long-Term Outcomes of Coronary-Artery Bypass Graft Surgery Versus Percutaneous Coronary Intervention for Multivessel Coronary Artery Disease in the Bare-Metal Stent Era , 2008, Circulation.
[4] D. Duprez. Systolic hypertension in the elderly: addressing an unmet need. , 2008, The American journal of medicine.
[5] G. Mancia,et al. Dogma Disputed: Can Aggressively Lowering Blood Pressure in Hypertensive Patients with Coronary Artery Disease Be Dangerous? , 2006, Annals of Internal Medicine.
[6] Patrick W Serruys,et al. Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial. , 2005, Journal of the American College of Cardiology.
[7] P. Poole‐Wilson,et al. Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with symptomatic stable angina and hypertension: the ACTION trial , 2005, Journal of hypertension.
[8] D. Holmes,et al. In-hospital and long-term outcomes of multivessel percutaneous coronary revascularization after acute myocardial infarction. , 2005, The American journal of cardiology.
[9] R. D'Agostino,et al. A likely explanation for the J-curve of blood pressure cardiovascular risk. , 2004, The American journal of cardiology.
[10] S. Lewington. Prospective studies collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies (vol 360, pg 1903, 2002) , 2003 .
[11] G. Breithardt,et al. Grade of chronic renal failure, and acute and long-term outcome after percutaneous coronary interventions. , 2003, Kidney international.
[12] R. Collins,et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies , 2002, The Lancet.
[13] François Gueyffier,et al. J-Shaped Relationship between Blood Pressure and Mortality in Hypertensive Patients: New Insights from a Meta-Analysis of Individual-Patient Data , 2002, Annals of Internal Medicine.
[14] M. Woodward,et al. Randomised trial of a perindopril-based blood pressure lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack , 2001 .
[15] N. Kaplan. J-curve not burned off by HOT study , 1998, The Lancet.
[16] Joël Ménard,et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial , 1998, The Lancet.
[17] C. Mulrow,et al. The J-curve phenomenon and the treatment of hypertension. Is there a point beyond which pressure reduction is dangerous? , 1991, JAMA.
[18] R. Collins,et al. Blood pressure, stroke, and coronary heart disease Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias , 1990, The Lancet.
[19] J. Cruickshank. Coronary flow reserve and the J curve relation between diastolic blood pressure and myocardial infarction. , 1988, BMJ.
[20] M. H. Gault,et al. Prediction of creatinine clearance from serum creatinine. , 1975, Nephron.
[21] S. Denardo,et al. Blood pressure targets after high-risk myocardial infarction: is it time to update the guidelines? , 2008, Hypertension.
[22] Eric J Topol,et al. Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial. , 2004, JAMA.
[23] R. Villareal,et al. Coronary artery bypass surgery versus coronary stenting: risk-adjusted survival rates in 5,619 patients. , 2002, Texas Heart Institute journal.